HopeStage
Back to all studies
CompletedNCT05383300

Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy

It focuses on personality disorders and currently lists study information in the United Kingdom.

Personality disorders, Personality disordersDrugFrom 18 Years to 60 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
London, United KingdomSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateStarted: May 1, 2017
Recruitment status
Completed
Enrollment listed in the registry
72
Sponsor
King's College London
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug, OTHER
Study phase
Not clearly listed
Locations
United Kingdom
Age range
From 18 Years to 60 Years
Official registry ID
NCT05383300
Official title
Investigating the Effect of Oxytocin and the Neurochemistry of Antisocial Personality Disorder and Psychopathy Using Neuroimaging

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

London

Registry details
Registry conditions (original wording)

Antisocial Personality Disorder

FAQ

Questions about this study

Who is behind this study?

The study sponsor is King's College London, a university.

Did this study involve medication?

Yes. The study involved medication, including Oxytocin nasal spray.

Who was this study for?

Listed age limits: 18 years to 60 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me